Home

Oportun Financial Corporation - common stock (OPRT)

5.1700
+0.0800 (1.57%)
NASDAQ · Last Trade: Nov 28th, 6:50 PM EST
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
One Fund Just Dumped $13 Million in This Offshore Drilling Stock — Here's What Long-Term Investors Should Knowfool.com
One fund just walked away from a rising offshore driller—here’s what long-term investors should make of the move.
Via The Motley Fool · November 27, 2025
This Small-Cap Consumer Stock Has Landed New Institutional Backing as Shares Surge 60%fool.com
A fast-growing niche segment may be the real reason this small-cap consumer products stock is drawing new institutional attention.
Via The Motley Fool · November 27, 2025
This Fund Leaned Into 2025's Big Biotech Rally with a $9.5 Million Bet on Mineralysfool.com
One small fund’s high-conviction move offers a window into how specialists are navigating 2025’s biotech rally.
Via The Motley Fool · November 27, 2025
Earnings Scheduled For November 4, 2025benzinga.com
Via Benzinga · November 4, 2025
Earnings Scheduled For August 6, 2025benzinga.com
Via Benzinga · August 6, 2025
An Overview of Oportun Financial's Earningsbenzinga.com
Via Benzinga · August 5, 2025
Earnings Scheduled For May 8, 2025benzinga.com
Via Benzinga · May 8, 2025
Earnings Scheduled For February 12, 2025benzinga.com
Via Benzinga · February 12, 2025
Earnings Scheduled For November 12, 2024benzinga.com
Via Benzinga · November 12, 2024
Curious about the stocks that are showing activity after the closing bell on Friday?chartmill.com
Let's have a look at what is happening on the US markets after the closing bell on Friday. Below you can find the top gainers and losers in today's after hours session.
Via Chartmill · March 21, 2025
OPRT Stock Earnings: Oportun Financial Beats EPS, Beats Revenue for Q2 2024investorplace.com
OPRT stock results show that Oportun Financial beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via InvestorPlace · August 8, 2024
Critical Insights From Oportun Financial Analyst Ratings: What You Need To Knowbenzinga.com
Via Benzinga · May 13, 2024
OPRT Stock Earnings: Oportun Financial Beats EPS, Beats Revenue for Q1 2024investorplace.com
OPRT stock results show that Oportun Financial beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via InvestorPlace · May 9, 2024
Demystifying Oportun Financial: Insights From 4 Analyst Reviewsbenzinga.com
Via Benzinga · April 24, 2024
Oportun Financial: Q4 Earnings Insightsbenzinga.com
Via Benzinga · March 12, 2024
Earnings Outlook For Oportun Financialbenzinga.com
Via Benzinga · March 11, 2024
Analyst Ratings for Oportun Financialbenzinga.com
Via Benzinga · November 28, 2023
Where Oportun Financial Stands With Analystsbenzinga.com
Via Benzinga · November 7, 2023
Crude Oil Moves Higher; General Motors Earnings Top Viewsbenzinga.com
Via Benzinga · April 23, 2024
Why Nucor Shares Are Trading Lower? Here Are Other Stocks Moving In Tuesday's Mid-Day Sessionbenzinga.com
Via Benzinga · April 23, 2024
Dow Jumps Over 200 Points; US Services PMI Falls In Aprilbenzinga.com
Via Benzinga · April 23, 2024
Earnings Scheduled For March 12, 2024benzinga.com
Companies Reporting Before The Bell • Aurora Mobile (NASDAQ:JG) is likely to report earnings for its fourth quarter.
Via Benzinga · March 12, 2024
GOOG Stock Alert: Alphabet Is Spending Money in All the Wrong Placesinvestorplace.com
The company continues to buy back Alphabet stock in large quantities. As for its other equity investments, it ought to stick with the S&P 500.
Via InvestorPlace · December 2, 2023
Crude Oil Falls Sharply; Datadog Shares Spike Higherbenzinga.com
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining around 1% on Tuesday The Dow traded up 0.21% to 34,166.89 while the NASDAQ rose 1.09% to 13,666.65. The S&P 500 also rose, gaining, 0.41% to 4,383.80.
Via Benzinga · November 7, 2023
Why Sanmina Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Tuesday's Mid-Day Sessionbenzinga.com
Gainers PaxMedica, Inc. (NASDAQ: PXMD) shares climbed 173.8% to $8.35. PaxMedica announced the publication of its autism spectrum disorder Phase 2 study results in the Annals of General Psychiatry.
Via Benzinga · November 7, 2023